Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ARMP Relative to the S&P 500

ARMP Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Armata Pharmaceuticals, Inc. (AMEX:ARMP) seasonal charts above shows that a Buy Date of December 30 and a Sell Date of March 25 has resulted in a geometric average return of 2.59% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 102.59% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

To download ARMP seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ARMP